Deferred taxes (Details) - Veraxa Biotech A G [Member] - CHF (SFr) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Entity Information [Line Items] | ||
| Tax losses (Switzerland) | SFr 19,610,769 | SFr 11,163,549 |
| Tax losses (Germany) | 34,639,558 | 25,153,116 |
| Total unrecognized deferred tax assets (expiring until 2028) | 54,250,327 | 36,316,665 |
| Possible tax effect | 16,817,601 | 10,197,629 |
| Capital increase expenses | 1,639,197 | 1,397,446 |
| Balancing | (1,639,197) | (1,397,446) |
| Balance sheet recognition of deferred tax assets | ||
| Intangible assets from addition Veraxa Biotech GmbH | (9,652,055) | (9,652,055) |
| Intangible assets from addition Synimmune GmbH | (8,840,889) | (8,840,889) |
| Amortization of intangible assets | 2,413,015 | 1,930,412 |
| Gross amount of deferred tax liabilities | (16,079,929) | (16,562,532) |
| Balancing | 1,639,197 | 1,397,446 |
| Balance sheet recognition of deferred tax liabilities | SFr (14,440,732) | SFr (15,165,086) |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|